American Journal of Clinical Dermatology

Papers
(The TQCC of American Journal of Clinical Dermatology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
The Current State of Systemic Therapy of Metastatic Uveal Melanoma153
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative143
Prognostic Biomarkers in Evolving Melanoma Immunotherapy139
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions128
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review97
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments94
Economic Burden of Chronic Hand Eczema: A Review94
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments86
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study84
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know79
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?71
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology70
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution67
Primary Localized Cutaneous Amyloidosis of Keratinocyte Origin: An Update with Emphasis on Atypical Clinical Variants66
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review63
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data54
A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris54
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi49
Behçet Disease: An Update for Dermatologists49
Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”48
Pathophysiology of Generalized Pustular Psoriasis48
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion47
Inpatient Teledermatology Improves Diagnostic Accuracy and Management of Leg Ulcers in Hospitalized Patients45
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment45
Disease Modification in Psoriasis: Future Prospects for Long-Term Remission45
Skin Cancer in People of Color: A Systematic Review44
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study44
Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature42
Lessons Learned from Orthopedics: A Call to Action for More Rigorous Platelet-Rich Plasma Hair Loss Clinical Trials42
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management41
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation41
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives39
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis39
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment39
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist37
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis37
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review37
A Practice Approach to Acne Fulminans in Adolescents37
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa36
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates36
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis36
Patient and Public Involvement in Dermatology Research: A Review33
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm33
Oral Lichen Planus: An Update on Diagnosis and Management33
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching33
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases32
Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons31
Individualized Neoantigen-Directed Melanoma Therapy30
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options30
Frontal Fibrosing Alopecia: An Update30
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”30
Targeting Inflammation in Acne: Current Treatments and Future Prospects29
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists29
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada29
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential28
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History28
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials28
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study27
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program26
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)26
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management25
Approach to the Atypical Wound25
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”24
Acknowledgement to Referees23
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea23
Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians23
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study23
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients23
Management of Acne in Pregnancy22
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study22
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis22
Investigational Treatments for Epidermolysis Bullosa22
Identifying and Treating Ocular Manifestations in Psoriasis21
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey21
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion 21
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year21
Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)21
An Update on New and Existing Treatments for the Management of Melasma20
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts20
Safety of Hydroxychloroquine: What a Dermatologist Should Know20
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials20
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights20
Review of Perineural Invasion in Keratinocyte Carcinomas20
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study19
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study19
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color19
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-219
0.078526020050049